Success Metrics

Clinical Success Rate
80.8%

Based on 21 completed trials

Completion Rate
81%(21/26)
Active Trials
3(7%)
Results Posted
52%(11 trials)
Terminated
5(12%)

Phase Distribution

Ph phase_2
7
17%
Ph phase_4
10
24%
Ph not_applicable
6
15%
Ph phase_1
4
10%
Ph phase_3
11
27%

Phase Distribution

4

Early Stage

7

Mid Stage

21

Late Stage

Phase Distribution38 total trials
Phase 1Safety & dosage
4(10.5%)
Phase 2Efficacy & side effects
7(18.4%)
Phase 3Large-scale testing
11(28.9%)
Phase 4Post-market surveillance
10(26.3%)
N/ANon-phased studies
6(15.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

65.6%

21 of 32 finished

Non-Completion Rate

34.4%

11 ended early

Currently Active

3

trials recruiting

Total Trials

41

all time

Status Distribution
Active(4)
Completed(21)
Terminated(11)
Other(5)

Detailed Status

Completed21
Withdrawn6
Terminated5
unknown4
Recruiting3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
41
Active
3
Success Rate
80.8%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (10.5%)
Phase 27 (18.4%)
Phase 311 (28.9%)
Phase 410 (26.3%)
N/A6 (15.8%)

Trials by Status

completed2151%
not_yet_recruiting12%
terminated512%
recruiting37%
suspended12%
withdrawn615%
unknown410%

Recent Activity

Clinical Trials (41)

Showing 20 of 41 trialsScroll for more
NCT03619850Phase 3

A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

Recruiting
NCT03893045Phase 3

A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects

Recruiting
NCT05251493Phase 3

Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy

Recruiting
NCT06596161Not Applicable

Iron Therpay and Fatigue in Women of Reprodcutive Age

Completed
NCT06487299Phase 2

Iron Administration Via Colonic TET Combined With WMT for ID

Not Yet Recruiting
NCT01052779Phase 2

A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease

Completed
NCT03933813Phase 1

Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients

Terminated
NCT01114204Phase 3

A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia

Completed
NCT01227616Phase 4

Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis

Completed
NCT05151679

Chelated Oral Iron Versus Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia Late in Pregnancy

Unknown
NCT03610230Not Applicable

Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients

Terminated
NCT03528564Phase 2

Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia

Terminated
NCT03591406Phase 3

To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia

Completed
NCT02707757Phase 4

Treatment Response in Dialysis Anaemia

Completed
NCT02940860Phase 3

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease

Completed
NCT02940886Phase 3

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

Completed
NCT03917394

Erythropoietin And/Or Iron Sucrose For Perioperative Anemia Management In Hip and Knee Arthroplasty

Unknown
NCT02047552Phase 2

RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone

Withdrawn
NCT03106298

Iron Deficiency and FGF23 Regulation in CKD and HF

Completed
NCT01180894Not Applicable

IV Iron for the Anemia of Traumatic Critical Illness

Completed

Drug Details

Intervention Type
DRUG
Total Trials
41